Product Information
NEFAZODONE HCL 150 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.2624 per EA under NDC 00093711306. Its NADAC has been published 390 times since Nov 28, 2013.
FDA first approved this application on Sep 16, 2003.
Strength
150 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093711306
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
NEFAZODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076037FDA Approved
9/16/2003
On Market Since
9/16/2003
Pharmacological Classes
Price Statistics
The NADAC for NEFAZODONE HCL 150 MG TABLET has been published 390 times since Nov 28, 2013, and over the history we have for it it has risen 138.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2624 per EA |
|---|---|
| All-time high | $1.3152 (Oct 12, 2016) |
| All-time low | $0.4903 (Apr 23, 2014) |
| 52-week high | $1.2624 |
| 52-week low | $1.2624 |
| Median price | $1.1993 |
| Average price | $1.0962 |
| Largest weekly change | +77.5% (Oct 15, 2014) |
| Weeks tracked | 390 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+3.1%
5Y
+3.1%
All
+138.4%
Last surveyed Feb 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Nefazodone Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nefazodone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEFAZODONE HCL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NEFAZODONE HCL 150 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $1.2624 per EA (NDC 00093711306), effective Feb 11, 2026.
How has the price of NEFAZODONE HCL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for NEFAZODONE HCL 150 MG TABLET has risen 138.4%. It has been tracked across 390 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEFAZODONE HCL 150 MG TABLET?
Since Nov 28, 2013, the NADAC for NEFAZODONE HCL 150 MG TABLET has ranged from a low of $0.4903 (Apr 23, 2014) to a high of $1.3152 (Oct 12, 2016), with a median of $1.1993 per EA.
Are there cheaper alternatives to NEFAZODONE HCL 150 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of NEFAZODONE HCL 150 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NEFAZODONE HCL 150 MG TABLET?
NEFAZODONE HCL 150 MG TABLET (NDC 00093711306) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.